Mufg Securities Emea PLC Bausch Health Companies Inc. Transaction History

Mufg Securities Emea PLC

6 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2020 Aug 13, 2020	SELL	$13.31 - $20.51 $21.1 Million - $32.6 Million	-1,588,900 Closed	0 $0
Q1 2020 May 12, 2020	BUY	$12.98 - $30.25 $10.9 Million - $25.4 Million	838,900 Added 111.85%	1,588,900 $24.6 Million
Q4 2019 Feb 11, 2020	BUY	$18.89 - $31.89 $14.2 Million - $23.9 Million	750,000 New	750,000 $22.4 Million
Q3 2019 Nov 12, 2019	SELL	$20.88 - $25.66 $31 Million - $38.1 Million	-1,486,700 Closed	0 $0
Q2 2019 Aug 13, 2019	BUY	$20.52 - $26.45 $12.8 Million - $16.5 Million	622,200 Added 71.97%	1,486,700 $37.5 Million
Q1 2019 May 14, 2019	BUY	$20.23 - $26.29 $17.5 Million - $22.7 Million	864,500 New	864,500 $21.4 Million

273

252M

5.12M

9.43M

Ticker BHC
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—Specialty & Generic
Shares Outstandng 361,728,000
Market Cap $1.57B
Description
Bausch Health Companies Inc., together with its subsidiaries, develops, manufactures, and markets a range of pharmaceutical, medical device, and over-the-counter (OTC) products primarily in the therapeutic areas of eye health, gastroenterology, and dermatology. The company operates through five segments: Bausch + Lomb, Salix, International Rx, O...

Get notified when there are updates to the investment portfolio of Mufg Securities Emea PLC, based on Form 13F filings with the SEC.

Stay updated on Mufg Securities Emea PLC with notifications on news.